Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02704234 · ClinicalTrials.gov registry record · NA

Acupuncture for Vulvodynia: A Pre-pilot Study

A NA study of Pain and Dyspareunia, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02704234: Completed NA study of Pain and Dyspareunia, sponsored by University of Illinois at Chicago.

NCT02704234 is a NA study of Pain and Dyspareunia that has completed, run by University of Illinois at Chicago. The registered enrollment target is 6 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02704234, a NA study of Pain and Dyspareunia, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Vulvodynia is a women's pain condition. Women have pain in their vulva, the area in their genitals between the vagina and labia (lips of the vagina). They also have pain when they have sexual intercourse or insert anything in the vagina. Sometimes they have so much pain, that they cannot have sex. This research is being done for two reasons. The first reason is to test a set of special needles called double-blinded acupuncture needles to give acupuncture treatments (one is a real needle and the other is a fake needle). The second reason is to develop a protocol (checklist) that will be used in this and future studies, and to identify and resolve any procedural problems. The protocol will be first tested by the principal investigator who is also an acupuncturist. The investigator will perform acupuncture using the protocol, if necessary change the protocol, and then teach a second acupuncturist using the modified protocol how to use the double-blinded acupuncture needles. The real needle called the penetrating needle penetrates the skin. The fake needle called the non-penetrating placebo touch needle does not penetrate the skin but it touches the skin so it feels like a needle is being inserted. It has a blunt tip. Participants can't see which needle they are getting acupuncture with because the needles are housed in a double-blinded needle device which has two tubes (an inner and an outer) that neither the acupuncturists nor the participants can see through. If a fake acupuncture needle can be used in acupuncture research like a sugar pill is used for drug studies to see how well the real medicine works, the investigators can see how effective acupuncture is. The investigators will be testing these needles to treat participants with vulvodynia.

Primary Outcome

PainReportIt, the computerized McGill Pain Questionnaire

Interventions

  • OTHER Active Acupuncture
  • OTHER Placebo Acupuncture

Study Locations (1)

Illinois

  • A Center for Oriental Medicine - Wilmette

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2018-02-23
Est. Completion 2022-11-07
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT02704234 record still lists

NCT02704234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Active Acupuncture is the first listed.

NCT02704234 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02704234 about?

NCT02704234 is a clinical study titled "Acupuncture for Vulvodynia: A Pre-pilot Study". Vulvodynia is a women's pain condition. Women have pain in their vulva, the area in their genitals between the vagina and labia (lips of the vagina). They also have pain when they have sexual intercourse or insert anything in the vagina. Sometimes they have so much pain, that they cannot have sex. ...

What is the current status of trial NCT02704234?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-02-23. Estimated completion is 2022-11-07.

What conditions does trial NCT02704234 study?

This clinical trial studies the following conditions: Pain, Dyspareunia, Vulvodynia, Vulvar Vestibulitis.

What interventions are being tested in trial NCT02704234?

The interventions under investigation include: Active Acupuncture (OTHER), Placebo Acupuncture (OTHER).

Who is sponsoring clinical trial NCT02704234?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02704234 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02704234's enrollment target sits among peer trials

6 373rd of 374 higher than 1 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02704234, the US trial registry maintained by the National Library of Medicine. NCT02704234 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.